These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8288678)

  • 41. [Significance of vasomotor reactions for gynecologic oncologic therapy].
    Neu E; Michailov MC; Welscher U; Tempel K; Willich N
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():206-7. PubMed ID: 7509674
    [No Abstract]   [Full Text] [Related]  

  • 42. Amsacrine (AMSA)--a clinical review.
    Louie AC; Issell BF
    J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antiblastic chemotherapy in gynecologic oncology].
    Vaglio N
    Arch Ostet Ginecol; 1969; 74(2):93-132. PubMed ID: 5406259
    [No Abstract]   [Full Text] [Related]  

  • 44. Topical treatment of condylomata acuminata with Solcoderm.
    Brokalakis J; Goumouzas N; Varelzidis A
    Dermatologica; 1984; 168 Suppl 1():49-51. PubMed ID: 6381155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current status of CDDP analogs in gynecologic malignancies].
    Yakushiji M; Nishimura H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1393-8. PubMed ID: 2658828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined modality therapy of gynecologic cancer.
    Brady LW
    Cancer; 1975 Jan; 35(1):76-83. PubMed ID: 1089040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical trials in gynecologic oncology: Past, present, and future.
    Annunziata CM; Kohn EC
    Gynecol Oncol; 2018 Feb; 148(2):393-402. PubMed ID: 29212614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New targeted cancer therapy for resistant gynecologic cancers.
    Bond T
    Womens Health (Lond); 2014 May; 10(3):233. PubMed ID: 24956290
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chemotherapy in the gynecologic oncology].
    Minerva Med; 1971 Apr; 62(28):1474-5. PubMed ID: 5567640
    [No Abstract]   [Full Text] [Related]  

  • 50. [Current and prospective role of antiblastic chemotherapy in gynecologic oncology].
    Macchioni B; Trompeo P
    Minerva Ginecol; 1968 Feb; 20(3):272-81. PubMed ID: 4190616
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical experience with the use of Tantum Rosa in cancer patients].
    Chulkova OV; Demidova LV; Udovichenko VI
    Vopr Onkol; 1997; 43(3):339-40. PubMed ID: 9245096
    [No Abstract]   [Full Text] [Related]  

  • 52. [Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms].
    Koto T; Tsunawaki A
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):4262-76. PubMed ID: 3729501
    [No Abstract]   [Full Text] [Related]  

  • 53. [Use of chemotherapy in oncogynecology].
    Nechaeva ID; Kotova DG
    Vopr Onkol; 1978; 24(3):106-15. PubMed ID: 347710
    [No Abstract]   [Full Text] [Related]  

  • 54. Taxanes in the management of gynecologic malignancies.
    Markman M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):219-26. PubMed ID: 18279063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cytostatic therapy of gynecological carcinoma].
    Vahrson H
    Fortschr Med; 1974 Mar; 92(9):363-8. PubMed ID: 4206636
    [No Abstract]   [Full Text] [Related]  

  • 56. Highlights in kidney cancer from the 2016 American Society of Clinical Oncology Annual Meeting.
    Clin Adv Hematol Oncol; 2016 Aug; 14(8):594-6. PubMed ID: 27487102
    [No Abstract]   [Full Text] [Related]  

  • 57. Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin.
    Lin LL; Lakomy DS; Ning MS; Simpkins F; Jhingran A
    Int J Gynecol Cancer; 2020 Apr; 30(4):409-423. PubMed ID: 32193219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chemotherapy during pregnancy: when and how? Particulars in gynecologic and breast cancers].
    Giacalone PL; Bénos P; Charlier C; Laffargue F
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):197-200. PubMed ID: 9471460
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cytogenetics of female genital cancer].
    Pescetto G; De Cecco L
    Minerva Med; 1967 May; 58(35):1669-70. PubMed ID: 6028214
    [No Abstract]   [Full Text] [Related]  

  • 60. Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies.
    Julius JM; Hammerstrom A; Wei C; Rajesh R; Bodurka DC; Kurian S; Smith JA
    J Oncol Pharm Pract; 2017 Mar; 23(2):121-127. PubMed ID: 26692242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.